Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Related Articles by Review for PubMed (Select 23067905)

1.

Pediatric cardiovascular safety: challenges in drug and device development and clinical application.

Bates KE, Vetter VL, Li JS, Cummins S, Aguel F, Almond C, Dubin AM, Elia J, Finkle J, Hausner EA, Joseph F, Karkowsky AM, Killeen M, Lemacks J, Mathis L, McMahon AW, Pinnow E, Rodriguez I, Stockbridge NL, Stockwell M, Tassinari M, Krucoff MW.

Am Heart J. 2012 Oct;164(4):481-92. doi: 10.1016/j.ahj.2012.07.019.

PMID:
23067905
2.

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.

Circulation. 2007 May 15;115(19):2549-69. Review.

3.

FDA's perspectives on cardiovascular devices.

Chen EA, Patel-Raman SM, O'Callaghan K, Hillebrenner MG.

J Cardiovasc Transl Res. 2009 Jun;2(2):143-6. doi: 10.1007/s12265-009-9096-7. Epub 2009 Mar 10. Review.

PMID:
20559979
4.

Current challenges for clinical trials of cardiovascular medical devices.

Zannad F, Stough WG, Piña IL, Mehran R, Abraham WT, Anker SD, De Ferrari GM, Farb A, Geller NL, Kieval RS, Linde C, Redberg RF, Stein K, Vincent A, Woehrle H, Pocock SJ.

Int J Cardiol. 2014 Jul 15;175(1):30-7. doi: 10.1016/j.ijcard.2014.05.021. Epub 2014 May 16. Review.

PMID:
24861254
5.

Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.

Serabian MA, Pilaro AM.

Toxicol Pathol. 1999 Jan-Feb;27(1):27-31. Review.

6.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
7.

Analgesia and anesthesia for neonates: study design and ethical issues.

Anand KJ, Aranda JV, Berde CB, Buckman S, Capparelli EV, Carlo WA, Hummel P, Lantos J, Johnston CC, Lehr VT, Lynn AM, Maxwell LG, Oberlander TF, Raju TN, Soriano SG, Taddio A, Walco GA.

Clin Ther. 2005 Jun;27(6):814-43. Review.

PMID:
16117988
8.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

9.

Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices.

Morford LL, Bowman CJ, Blanset DL, Bøgh IB, Chellman GJ, Halpern WG, Weinbauer GF, Coogan TP.

Birth Defects Res B Dev Reprod Toxicol. 2011 Aug;92(4):359-80. doi: 10.1002/bdrb.20305. Epub 2011 Jul 18. Review.

PMID:
21770023
10.

Juvenile animal studies and pediatric drug development: a European regulatory perspective.

Carleer J, Karres J.

Birth Defects Res B Dev Reprod Toxicol. 2011 Aug;92(4):254-60. doi: 10.1002/bdrb.20310. Epub 2011 Jun 2. Review.

PMID:
21638754
11.

Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007.

Berger JS, Bairey-Merz CN, Redberg RF, Douglas PS; DCRI Think Tank.

Am Heart J. 2008 Nov;156(5):816-25, 825.e1. doi: 10.1016/j.ahj.2008.06.039. Epub 2008 Sep 18. Review.

PMID:
19061693
12.

Pharmacologic management of insomnia in children and adolescents: consensus statement.

Mindell JA, Emslie G, Blumer J, Genel M, Glaze D, Ivanenko A, Johnson K, Rosen C, Steinberg F, Roth T, Banas B.

Pediatrics. 2006 Jun;117(6):e1223-32.

PMID:
16740821
14.

Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.

Heinonen TM, Aamer M, Marshall C, Black DM, Tardif JC.

Expert Rev Cardiovasc Ther. 2012 Aug;10(8):989-94. doi: 10.1586/erc.12.84. Review.

PMID:
23030288
15.

Cardiovascular support in preterm infants.

Evans JR, Lou Short B, Van Meurs K, Cheryl Sachs H.

Clin Ther. 2006 Sep;28(9):1366-84. Review.

PMID:
17062310
16.

Alternative strategies in drug development: clinical pharmacological aspects.

Kuhlmann J.

Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Review.

PMID:
10599949
17.

Cardiovascular drug development: is it dead or just hibernating?

Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM.

J Am Coll Cardiol. 2015 Apr 21;65(15):1567-82. doi: 10.1016/j.jacc.2015.03.016. Review.

PMID:
25881939
18.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
19.
20.

Criteria supporting the study of drugs in the newborn.

Ward RM, Benitz WE, Benjamin DK Jr, Blackmon L, Giacoia GP, Hudak M, Lasky T, Rodriguez W, Selen A.

Clin Ther. 2006 Sep;28(9):1385-98. Review.

PMID:
17062311
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk